ScreenerHero

VVY Vivoryon Therapeutics N.V.

AMS · NL · Healthcare · Biotechnology · vivoryon.com
1.100EUR0.00%Mkt Cap: 35.41M $P/E: —

Vivoryon Therapeutics N.V. operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap35.41M USD
Enterprise Value32.83M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.62M USD
Revenue/Share—
Last Price1.100 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryNL
SectorHealthcare
IndustryBiotechnology
ISINNL00150002Q7
Valuation
P/E (Trailing)—
P/E (Forward)-3.55
PEG—
EV/EBITDA-4.51
EV/Revenue—
P/S—
P/B20.75
EPS (TTM)-0.23
EPS (Forward)-0.31
52W Range
1.02010% of range1.840
52W High1.840 EUR
52W Low1.020 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-187.29%
ROA-117.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.19M USD
CapEx (TTM)6.52K USD
FCF Margin—
FCF Yield-11.53%
Net Debt-2.58M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.02
Current Ratio4.56
Quick Ratio4.03
Book Value/Sh0.05 EUR
Cash/Share0.08 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.850 EUR
Upside (mean)+522.7%
Target Range6.850 EUR – 6.850 EUR
# Analysts1
Ownership
Shares Out.29.61M
Float26.35M
Insiders4.85%
Institutions8.90%
Technical
SMA 501.133 (-2.9%)
SMA 2001.275 (-13.7%)
Beta1.44
S&P 52W Chg14.58%
Avg Vol (30d)17.20K
Avg Vol (10d)19.66K
Technical Indicators
RSI (14)45.3
MACD-0.0103
MACD Signal-0.0117
MACD Hist.+0.0015
BB Upper1.136 EUR
BB Middle1.107 EUR
BB Lower1.077 EUR
BB Width5.35%
ATR (14)0.0349 EUR
Vol Ratio (20d)1.57x